Favipiravir Impurity 6 | CAS 356783-29-4 - Request Quote
Favipiravir Impurity 6
| SZ CAT No: | SZ-F056007 |
| CAS No | 356783-29-4 |
| Mol.F. | C5H3F2N3O |
| Mol.Wt. | 159.1 |
| Inv. Status | Synthesis on demand |
| Shipping Condition | Room Temperature |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Favipiravir Impurity 6 is chemically 3,6-Difluoropyrazine-2-carboxamide. Favipiravir Impurity 6 is supplied with detailed characterization data compliant with regulatory guideline. Favipiravir Impurity 6 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Favipiravir.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 356783-29-4
Purchase 356783-29-4
Order 356783-29-4
Enquire 356783-29-4
price of 356783-29-4
356783-29-4 Supplier
356783-29-4 Manufacturer
356783-29-4 Exporter
buy high quality Favipiravir Impurity 6
Purchase Favipiravir Impurity 6
Favipiravir Impurity 6 suppliers
Favipiravir Impurity 6 manufacturers
Favipiravir Impurity 6 price
Order Favipiravir Impurity 6
Enquire Favipiravir Impurity 6
Favipiravir Impurity 6 cost
Favipiravir Impurity 6 Supplier
Favipiravir Impurity 6 Distributor
Favipiravir Impurity 6 for Method Validation
Favipiravir Reference Standard
Favipiravir Impurity 6 for ANDA Filing
Favipiravir Impurity 6 for Forced Degradation Studies
Favipiravir Impurity 6 Identification Standards
Favipiravir Impurity 6 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.